Point72 Asset Management
NXTM

Point72 Asset Management’s NxStage Medical Inc. NXTM Stock Holding History

Point72 Asset Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-81,748
Closed -$2.26M – 1192
2017
Q3 		$2.26M Sell
81,748
-185,152
-69% -$4.94M 0.01% 665
2017
Q2 		$6.69M Buy
+266,900
New +$6.61M 0.04% 469
2016
Q2 		– Sell
-325,000
Closed -$4.87M – 938
2016
Q1 		$4.87M Sell
325,000
-273,300
-46% -$4.58M 0.04% 432
2015
Q4 		$13.1M Sell
598,300
-395,200
-40% -$7.36M 0.11% 219
2015
Q3 		$15.7M Sell
993,500
-276,100
-22% -$4.43M 0.12% 232
2015
Q2 		$18.1M Buy
1,269,600
+274,895
+28% +$4.66M 0.13% 215
2015
Q1 		$17.2M Buy
994,705
+499,505
+101% +$8.83M 0.12% 227
2014
Q4 		$8.88M Sell
495,200
-510,100
-51% -$8.21M 0.06% 348
2014
Q3 		$13.2M Buy
1,005,300
+32,100
+3% +$432K 0.1% 238
2014
Q2 		$14M Buy
+973,200
New +$12.7M 0.09% 266

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's NXTM Position: Q4 2017 in Review

Point72 Asset Management sold out of NxStage Medical Inc. (NXTM) in Q4 2017, closing a stake of 81,748 shares — an estimated $2.26M sold.

Point72 Asset Management first reported a position in NXTM in Q2 2014 and held it in 10 quarters. The position peaked at $18.1M in Q2 2015. 178 funds tracked by Wall St. Rank hold NXTM as of Q4 2017.

  • Point72 Asset Management reported no remaining NxStage Medical Inc. position as of Q4 2017 after selling out during the quarter.
  • Point72 Asset Management sold 81,748 NxStage Medical Inc. shares in Q4 2017, an estimated $2.26M.
  • Point72 Asset Management first reported a position in NxStage Medical Inc. in Q2 2014 and held it in 10 quarters.
  • Point72 Asset Management's NxStage Medical Inc. position peaked at $18.1M in Q2 2015.
  • 178 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2017.

Based on Point72 Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.